Glial cell line-derived neurotrophic factor improves survival of dopaminergic neurons in transplants of fetal ventral mesencephalic tissue

Experimental Neurology

Volumn 153, Issue 2, 1998, Pages 195-202

  Yurek, David M ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CILIARY NEUROTROPHIC FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR;

ANIMAL TISSUE; ARTICLE; CELL GROWTH; CELL SURVIVAL; CELL SUSPENSION; CIRCLING BEHAVIOR; CORPUS STRIATUM; DENERVATION; DOPAMINERGIC NERVE CELL; FETUS (ANATOMY); MESENCEPHALON; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; TISSUE GRAFT; TISSUE TRANSPLANTATION;

EID: 0032192007     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1998.6884     Document Type: Article

References (31)

1. Altar C. A., Wiegand S. J., Lindsay R. M., Cedarbaum J. M. Neurotrophic factors: Towards a restorative therapy of Parkinson's disease. Neuroprotective Approaches to the Treatment of Neurodegenerative Disease. 1996;Academic Press, London. p. 160-180.
2. Apostolides C., Sanford E., Hong M., Mendez I. Glial cell line-derived neurotrophic factor improves intrastriatal graft survival of stored dopaminergic cells. Neuroscience. 83:1998;363-372.
3. Beck K. D., Valverde J., Alexl T., Poulsen K., Moffat B., Vandlen R. A., Rosenthal A., Hefti F. Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature. 373:1995;339-341.
4. Cass W. A. GDNF selectively protects dopamine neurons over serotonin neurons against the neurotoxic effects of methamphetamine. J. Neurosci. 16:1996;8132-8139.
5. Cenci M. A., Björklund A. Transection of corticostriatal afferents abolishes the hyperexpression of Fos and counteracts the development of rotational overcompensation induced by intrastriatal dopamine-rich grafts when challenged with amphetamine. Brain Res. 665:1994;167-174.
6. Choi-Lundberg D. L., Lin Q., Chang Y. N., Chang Y. L., Hay C. M., Mohajeri H., Davidson B. L., Bohn M. C. Dopaminergic neurons protected from degeneration by GDNF gene therapy. Science. 275:1997;838-841.
7. Ebendal T. Function and evolution in the NGF family and its receptors. J. Neurosci. Res. 32:1992;461-470.
8. Gash D. M., Zhang Z., Ovadia A., Cass W. A., Yi A., Simmerman L., Russell D., Martin D., Lapchak P. A., Collins F., Hoffer B. J., Gerhardt G. A. Functional recovery in parkinsonian monkeys treated with GDNF. Nature. 380:1996;252-255.
9. Giacobini M. M. J., Hoffer B. J., Zerbe G., Olson L. Acidic and basic fibroblast growth factors augment growth of fetal brain tissue grafts. Exp. Brain Res. 86:1991;73-81.
10. Giacobini M. M. J., Alström S., Funa K., Olson L. Differential effects of platelet-derived growth factor isoforms on dopamine neuronsin vivo. Neuroscience. 57:1993;923-929.
11. Hudson J., Granholm A.-C., Gerhardt G. A., Henry M. A., Hoffman A., Biddle P., Leela N. S., Mackerlova L., Lile J. D., Collins F., Hoffer B. J. Glial cell line-derived neurotrophic factor augments midbrain dopaminergic circuitsin vivo. Brain Res. Bull. 36:1995;425-432.
12. Johansson M., Friedemann M., Hoffer B. J., Strömberg I. Effects of glial cell line-derived neurotrophic factor on developing and mature ventral mesencephalic graftsin oculo. Exp. Neurol. 134:1995;25-34.
13. Kearns C. M., Gash D. M. GDNF protects nigral dopamine neurons against 6-hydroxydopaminein vivo. Brain Res. 672:1995;104-111.
14. Mandel R. J., Spratt S. K., Snyder R. O., Leff S. E. Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rats. Proc. Natl. Acad. Sci. USA. 94:1997;14,083-14,088.
15. Mayer E., Fawcett J. W., Dunnett S. B. Basic fibroblast growth factor promotes the survival of embryonic ventral mesencephalic dopaminergic neurons. II. Effects on nigral transplantsin vivo. Neuroscience. 56:1993;389-398.
16. Meakin S. O., Shooter E. M. The nerve growth factor family of receptors. Trends Neurosci. 15:1992;323-331.
17. Olanow C. W., Kordower J. H., Freeman T. B. Fetal nigral transplantation as a therapy for Parkinson's disease. Trends Neurosci. 19:1996;102-109.
18. Rosenblad C., Martinez-Serrano A., Björklund A. Glial cell line-derived neurotrophic factor increases survival, growth and function of intrastriatal fetal nigral dopaminergic grafts. Neuroscience. 75:1996;979-985.
19. Seroogy K. B., Gall C. M. Expression of neurotrophins by midbrain dopaminergic neurons. Exp. Neurol. 124:1993;119-128.
20. Sinclair S. R., Svendsen C. N., Torres E. M., Martin D., Fawcett J. W., Dunnett S. B. GDNF enhances dopaminergic cell survival and fibre outgrowth in embryonic nigral grafts. NeuroReport. 7:1996;2547-2552.
21. Squinto S. P., Stitt T. N., Aldrich T. H., Davis S., Bianco S. M., Radziejewski C., Glass D. J., Masiakowski P., Furth M. E., Valenzuela D. M., DiStefano P. S., Yancopoulos G. D. trkB encodes a functional receptor for brain-derived neurotrophic factor and neurotrophin-3 but not NGF. Cell. 65:1991;885-893.
22. Steinbusch H. W. M., Vermeulen R. J., Tonnaer J. A. D. M. Basic fibroblast growth factor enhances survival and sprouting of fetal dopaminergic cells implanted in the denervated rat caudate-putamen: preliminary observations. Prog. Brain Res. 82:1990;81-86.
23. Strömberg I., Björklund L., Johansson M., Tomac A., Collins F., Olson L., Hoffer B., Humpel C. Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neuronsin vivo. Exp. Neurol. 124:1993;401-412.
24. Takayama H., Ray J., Raymon H. K., Baird A., Hogg J., Fisher L. J., Gage F. H. Basic fibroblast growth factor increases dopaminergic graft survival and function in a rat model of Parkinson's disease. Nature Med. 1:1995;53-58.
25. Tomac A., Lin E., Ögren L.-F. H., Young D., Hoffer B. J., Olson L. Protection and repair of the nigrostriatal dopaminergic system by GDNFin vivo. Nature. 373:1995;335-339.
26. Wang Y., Tien L. T., Lapchak P. A., Hoffer B. J. GDNF triggers fiber outgrowth of fetal ventral mesencephalic grafts from the nigra to striatum in 6-OHDA-lesioned rats. Cell Tissue Res. 286:1996;225-233.
27. Watson R. E. Jr., Wiegand S. J., Clough R. L., Hoffman G. E. Use of cryoprotectant to maintain long-term peptide immunoreactivity and tissue morphology in free-floating sections. Peptides. 7:1986;155-159.
28. Yurek, D. M. W. Lu, S. B. Hipkens, S. J. Wiegand, 1995, Functional reinnervation of the striatum by transplanted fetal dopamine neurons is enhanced after delayed infusions of BDNF.
29. Yurek D. M., Lu W., Hipkens S. B., Wiegand S. J. BDNF enhances the functional reinnervation of the striatum by grafted fetal dopamine neurons. Exp. Neurol. 137:1996;105-118.
30. Yurek D. M., Hipkens S. B., Wiegand S. J., Altar C. A. Optimal effectiveness of BDNF for fetal nigral transplants coincides with the ontogenic appearance of BDNF in the striatum. J. Neurosci., 18:1998;6040-6047.
31. Zeng B. Y., Jenner P., Marsden C. D. Altered motor function and graft survival produced by basic fibroblast growth factor in rats with 6-OHDA lesions and fetal ventral mesencephalic grafts are associated with glial proliferation. Exp. Neurol. 139:1996;214-226.